RNA5SP416

Across TCGA pan-cancer cohorts, RNA5SP416 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RNA5SP416 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher RNA5SP416 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNA5SP416 expression acts as an unfavorable survival marker, although some lineages such as OV show a favorable association.

UCS, STAD, and KIRC are the cancer types where RNA5SP416 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	All	0.001	0.690	<.001	108	view →
STAD	DFS	Tertile	All	0.164	0.558	<.001	72	view →
KIRC	DFS	Tertile	IV	0.100	0.619	.004	57	view →
UCEC	DFS	Tertile	IV	0.206	0.704	.033	18	view →
BLCA	DFS	Tertile	III,IV	0.159	0.572	.036	9	view →
LGG	DFS	Tertile	All	0.161	0.753	<.001	9	view →
OV	OS	Tertile	IV	1.000	0.336	.007	6	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RNA5SP416–UCS (OS)

Open the UCS breakdown →